Volume 134, Issue 2, Pages (February 2008)

Slides:



Advertisements
Similar presentations
Diet Study for Nonalcoholic Fatty Liver Disease Lab meeting.
Advertisements

Volume 139, Issue 6, Pages e1 (December 2010)
Volume 139, Issue 3, Pages e6 (September 2010)
Volume 153, Issue 3, Pages (September 2017)
Alas! Ileal Interposition Surgery for Diabetes Prevention?
Abnormal Liver Tests and Fatty Liver on Ultrasound
Bin Gao, Hidekazu Tsukamoto  Gastroenterology 
Volume 148, Issue 4, Pages (April 2015)
From Fat to Inflammation
Volume 153, Issue 3, Pages (September 2017)
Lipids in Liver Disease: Looking Beyond Steatosis
Volume 153, Issue 3, Pages e7 (September 2017)
Obesity Heats Up Adipose Tissue Lymphocytes
Volume 153, Issue 3, Pages e7 (September 2017)
Obesity and Atherogenic Dyslipidemia
Volume 146, Issue 3, Pages (March 2014)
Outcomes Among Living Liver Donors
Management of Dyslipidemia as a Cardiovascular Risk Factor in Individuals With Nonalcoholic Fatty Liver Disease  Kathleen E. Corey, Naga Chalasani  Clinical.
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Volume 149, Issue 2, Pages (August 2015)
Volume 134, Issue 2, Pages (February 2008)
Stephen A. Harrison, MD, FACP  Clinical Gastroenterology and Hepatology 
Volume 154, Issue 5, Pages (April 2018)
Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial  David Houghton, Christian.
Volume 139, Issue 1, Pages (July 2010)
Amir Klein, Michael J. Bourke  Gastroenterology 
Volume 135, Issue 4, Pages (October 2008)
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
Jean-Michel Pawlotsky  Gastroenterology 
Volume 137, Issue 3, Pages (September 2009)
Sugar, Sugar Not So Sweet for the Liver
Abstracts from Around the World
Volume 156, Issue 3, Pages (February 2019)
Figure 6 Possible therapeutic targets to decrease hepatic steatosis
Volume 139, Issue 2, Pages (August 2010)
Volume 133, Issue 2, Pages (August 2007)
Abnormal Liver Tests and Fatty Liver on Ultrasound
Postprandial Uridine Physiology Is Altered by Obesity
Nicolas Goossens, Yujin Hoshida  Gastroenterology 
Alas! Ileal Interposition Surgery for Diabetes Prevention?
Constance E. Ruhl, James E. Everhart  Gastroenterology 
Volume 133, Issue 2, Pages (August 2007)
AGA technical review on nonalcoholic fatty liver disease
Volume 62, Issue 6, Pages (June 2015)
Volume 19, Issue 2, Pages (February 2014)
Volume 148, Issue 3, Pages (March 2015)
Volume 145, Issue 2, Pages e3 (August 2013)
Association of Nonalcoholic Fatty Liver Disease With Visceral Adiposity but Not Coronary Artery Calcification in the Elderly  Kathleen Jacobs, Sharon.
Refining Sample-Size Estimations Based Upon Placebo Response in Trials of Agents for Nonalcoholic Fatty Liver Disease  Veeral Ajmera, MD, MAS, Rohit Loomba,
Volume 150, Issue 7, Pages (June 2016)
Volume 142, Issue 7, Pages e2 (June 2012)
Covering the Cover Gastroenterology
Lipids in Liver Disease: Looking Beyond Steatosis
The Dawning of a New Editorial Board for Gastroenterology
Volume 142, Issue 4, Pages e6 (April 2012)
Swaroop Pendyala, Jeanne M. Walker, Peter R. Holt  Gastroenterology 
Covering the Cover Gastroenterology
Volume 135, Issue 1, Pages (July 2008)
Liver, Muscle, and Adipose Tissue Insulin Action Is Directly Related to Intrahepatic Triglyceride Content in Obese Subjects  Kevin M. Korenblat, Elisa.
Volume 139, Issue 6, Pages e1 (December 2010)
Would Free Fatty Acids Enhance Treatment of Obesity?
Volume 155, Issue 6, Pages (December 2018)
Trunk Fat as a Determinant of Liver Disease
End-Stage Liver Disease in 2008: Finally a Glass Half Full
María Belén Acevedo, Ph. D. , Ramiro Ferrando, Bruce W. Patterson, Ph
Controversies in Liver Transplantation for Hepatitis C
Amir Klein, Michael J. Bourke  Gastroenterology 
Volume 135, Issue 6, Pages (December 2008)
Presentation transcript:

Volume 134, Issue 2, Pages 424-431 (February 2008) Alterations in Adipose Tissue and Hepatic Lipid Kinetics in Obese Men and Women With Nonalcoholic Fatty Liver Disease  Elisa Fabbrini, B. Selma Mohammed, Faidon Magkos, Kevin M. Korenblat, Bruce W. Patterson, Samuel Klein  Gastroenterology  Volume 134, Issue 2, Pages 424-431 (February 2008) DOI: 10.1053/j.gastro.2007.11.038 Copyright © 2008 AGA Institute Terms and Conditions

Figure 1 Whole-body palmitate rate of appearance (Ra) in plasma in subjects with normal intrahepatic triglyceride (IHTG) content and increased IHTG content (nonalcoholic fatty liver disease [NAFLD]). *Value significantly different from the Normal IHTG group value, P < .05. Gastroenterology 2008 134, 424-431DOI: (10.1053/j.gastro.2007.11.038) Copyright © 2008 AGA Institute Terms and Conditions

Figure 2 (A) Total VLDL-TG secretion rate (sum of shaded and open bars) in subjects with normal and increased (nonalcoholic fatty liver disease [NAFLD]) intrahepatic triglyceride (IHTG) content. Open bars represent fatty acids in VLDL-TG that originated from systemic plasma free fatty acids, presumably derived primarily from lipolysis of subcutaneous fat, whereas shaded bars represent fatty acids in VLDL-TG that originated from nonsystemic fatty acids, presumably derived primarily from lipolysis of intrahepatic and visceral fat and de novo lipogenesis. *Value significantly different from corresponding value in the normal IHTG group, P < .05. (B) VLDL-apoB100 secretion rates in the subjects with normal IHTG content (open bar) and NAFLD (solid bar). Values for each group are not significantly different from each other. (C) Molar ratio of VLDL-TG and VLDL-apoB100 secretion rates, an index of the average TG content of nascent VLDL particles, in subjects with normal IHTG content (open bar) and NAFLD (solid bar). *Value significantly different from value in the normal IHTG group, P < .01. Gastroenterology 2008 134, 424-431DOI: (10.1053/j.gastro.2007.11.038) Copyright © 2008 AGA Institute Terms and Conditions

Figure 3 Relationship between VLDL-TG secretion rate and intrahepatic triglyceride content (IHTG) in subjects with normal IHTG (open boxes) and nonalcoholic fatty liver disease (NAFLD) (solid boxes). Gastroenterology 2008 134, 424-431DOI: (10.1053/j.gastro.2007.11.038) Copyright © 2008 AGA Institute Terms and Conditions